Aardvark Therapeutics
San Diego
About Aardvark Therapeutics
Aardvark Therapeutics specializes in small molecule therapeutics for obesity and rare genetic metabolic disorders. Aardvark Therapeutics was founded by Tien Lee in 2017.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Total funding: $129.0M
- Funding stage: IPO
- Last round: Series C (May 2024)
- Ticker: nasdaq:AARD
- Website: aardvarktherapeutics.com
- Phone: 858-225-7696
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/aardvark-therapeutics-90020 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.